肝移植市場：世界の産業分析、規模、シェア、成長、動向、予測、2025年～2032年

Persistence Market Research社はこのほど、世界の肝移植市場に関する広範なレポートを発行しました。当レポートでは、市場促進要因・動向・機会・課題などの主要な市場力学を包括的に分析し、市場構造に関する深い洞察を提供しています。

主要な洞察

• 肝移植の市場規模（2025E）：19億100万米ドル
• 予測市場価値（2032F）：30億1,010万米ドル
• 世界市場成長率（CAGR 2025～2032年）：6.8%

肝移植市場 - レポート範囲：

肝移植市場には、肝硬変、肝細胞がん、急性肝不全などの重篤な肝疾患の治療に使用される肝移植のための様々な手技、技術、ドナー供給源が含まれます。この市場には、死体移植と生体肝移植の両方の技術が含まれ、外科手術、免疫抑制剤、術後ケアの進歩が成長の原動力となっています。肝疾患の有病率の増加と臓器提供の受け入れ拡大が、市場拡大に拍車をかけています。

市場成長の促進要因：

世界の肝移植市場を牽引している主な要因はいくつかあります。アルコール摂取、ウイルス性肝炎、非アルコール性脂肪性肝疾患（NAFLD）などによる肝疾患の罹患率が上昇したことで、肝移植の需要が大幅に増加しています。さらに、低侵襲移植やロボット支援手術などの手術技術の進歩により、成功率や患者の転帰が改善されています。新しい免疫抑制剤の開発も臓器拒絶反応のリスクを低減し、市場の成長をさらに後押ししています。さらに、臓器提供や移植のインフラ開拓を促進する政府の取り組みや意識向上プログラムが市場拡大を後押しすると期待されています。

市場抑制要因：

有望な成長見通しにもかかわらず、肝移植市場はいくつかの課題に直面しています。特に発展途上国では、術前、手術、術後の費用を含む肝移植の高額な費用が依然として大きな障壁となっています。ドナー臓器の入手可能性が限られているため、市場の成長はさらに制限され、必要とする患者の長い待機リストと死亡率の上昇につながっています。さらに、感染症、臓器拒絶反応、免疫抑制療法の副作用といった移植後の合併症が、移植の成功に向けた課題となっています。臓器調達に関する厳しい規制要件や倫理的懸念も、市場拡大に影響を与えています。

市場機会：

同市場は、臓器保存と移植技術の技術的進歩によって大きな機会をもたらしています。ドナー肝臓の生存率を高め、保存期間を延長する機械灌流技術のイントロダクションより、移植成功率の向上が期待されます。3Dプリント肝組織や幹細胞療法など、生体工学や再生医療の採用が増加していることは、従来の移植に代わる有望な選択肢を提供しています。さらに、移植センターへの投資の増加、ヘルスケア機関同士の連携、生体ドナープログラムを推進するイニシアティブは、新たな成長の道を提供します。新興経済諸国における医療アクセスの拡大と有利な償還政策も市場開拓に貢献しています。

本レポートで扱う主な質問

• 肝移植市場の世界の成長を促進する主な要因は何か？
• 技術の進歩は肝移植市場の競合情勢にどのような影響を与えているか？
• 肝移植患者やヘルスケアプロバイダーが直面する主な課題は何か？
• 肝移植市場の主要プレイヤーは誰で、競争力を維持するためにどのような戦略を採用しているのか？
• 世界の肝移植市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 市場の範囲と定義
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
  • 主な動向
• 製品タイプライフサイクル分析
• 肝移植市場：バリューチェーン
  • 原材料サプライヤー一覧
  • メーカー一覧
  • 販売代理店一覧
  • アプリケーション一覧
  • 収益性分析
• ポーターファイブフォースの分析
• 地政学的緊張：市場への影響
• マクロ経済要因
  • 世界のセクター別展望
  • 世界のGDP成長見通し
  • 世界の親市場概要
• 予測要因 - 関連性と影響
• 規制とテクノロジーの情勢

第3章 世界の肝移植市場の展望：過去（2019～2023年）および予測（2025～2032年）

• 主なハイライト
  • 市場規模（単位）予測
  • 市場規模と前年比成長率
  • 絶対的収益機会
• 市場規模（百万米ドル）分析と予測
  • 過去の市場規模分析、2019～2023年
  • 現在の市場規模予測、2025～2032年
• 世界の肝移植市場の展望：製品タイプ
  • イントロダクション/主な調査結果
  • 過去の市場規模（百万米ドル）と数量（単位）分析、2019～2023年、製品タイプ別
  • 現在の市場規模（百万米ドル）と数量（単位）予測、2025～2032年、製品タイプ別
    • 臓器保存ソリューション
    • 免疫抑制薬
    • その他
• 市場の魅力分析：製品タイプ
• 世界の肝移植市場の展望：治療タイプ
  • イントロダクション/主な調査結果
  • 過去の市場規模（百万米ドル）と数量（単位）分析、2019～2023年、治療タイプ別
  • 現在の市場規模（百万米ドル）と数量（単位）予測、2025～2032年、治療タイプ別
    • 肝移植手術
    • 術後拒絶反応抑制治療
    • シクロスポリン
    • タクロリムス
    • シロリムスプレドニゾンアザチオプリン
    • ミコフェノール酸モフェチル
• 市場の魅力分析：治療タイプ
• 世界の肝移植市場の展望：最終用途
  • イントロダクション/主な調査結果
  • 過去の市場規模（百万米ドル）と数量（単位）分析、2019～2023年、最終用途別
  • 現在の市場規模（百万米ドル）と数量（単位）予測、2025～2032年、最終用途別
    • 病院
    • 成人肝移植センター
    • 外来手術センター
• 市場の魅力分析：最終用途

第4章 世界の肝移植市場の展望：地域

• 主なハイライト
• 過去の市場規模（百万米ドル）と数量（単位）分析、2019～2023年、地域別
• 現在の市場規模（百万米ドル）と数量（単位）予測、2025～2032年、地域別
  • 北米
  • 欧州
  • 東アジア
  • 南アジア・太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• 市場の魅力分析：地域

第5章 北米の肝移植市場の展望：過去（2019～2023年）および予測（2025～2032年）

第6章 欧州の肝移植市場の展望：過去（2019～2023年）および予測（2025～2032年）

第7章 東アジアの肝移植市場の展望：過去（2019～2023年）および予測（2025～2032年）

第8章 南アジアおよびオセアニアの肝移植市場の展望：過去（2019～2023年）および予測（2025～2032年）

第9章 ラテンアメリカの肝移植市場の展望：過去（2019～2023年）および予測（2025～2032年）

第10章 中東およびアフリカの肝臓移植市場の展望：過去（2019～2023年）および予測（2025～2032年）

第11章 競合情勢

• 市場シェア分析、2024年
• 市場構造
  • 市場別の競合激化マップ
  • 競合免疫抑制薬
  • 見かけの製品容量
• 企業プロファイル（詳細 - 概要、財務、戦略、最近の動向）
  • Allosource
  • Conatus Pharmaceuticals Inc.
  • Digna Biotech SL
  • Dompe Farmaceutici SpA
  • Isogenis, Inc.
  • RedHill Biopharma Ltd.
  • Thompson Surgical
  • Integra Life Sciences
  • Baxter International Inc.
  • XVIVO
  • VirTech Bio
  • Vital Therapies
  • HepaTx

第12章 付録

• 調査手法
• 調査の前提
• 頭字語と略語

Persistence Market Research has recently published an extensive report on the global Liver Transplantation Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

• Liver Transplantation Market Size (2025E): USD 1901 Mn
• Projected Market Value (2032F): USD 3010.1 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 6.8%

Liver Transplantation Market - Report Scope:

The Liver Transplantation Market encompasses a range of procedures, technologies, and donor sources for liver transplants, primarily used to treat severe liver diseases, including cirrhosis, hepatocellular carcinoma, and acute liver failure. The market involves both cadaveric and living donor transplantation techniques, with advancements in surgical procedures, immunosuppressive drugs, and post-operative care driving growth. The increasing prevalence of liver diseases, coupled with the growing acceptance of organ donation, is fueling market expansion.

Market Growth Drivers:

Several key factors are driving the global Liver Transplantation Market. The rising incidence of liver diseases due to alcohol consumption, viral hepatitis, and non-alcoholic fatty liver disease (NAFLD) has significantly increased the demand for liver transplants. Moreover, advancements in surgical techniques, including minimally invasive transplantation and robotic-assisted surgeries, have improved success rates and patient outcomes. The development of new immunosuppressive drugs has also reduced the risk of organ rejection, further supporting market growth. Additionally, government initiatives and awareness programs promoting organ donation and transplantation infrastructure development are expected to boost market expansion.

Market Restraints:

Despite promising growth prospects, the Liver Transplantation Market faces several challenges. The high cost of liver transplantation, including pre-operative, surgical, and post-operative expenses, remains a significant barrier, particularly in developing countries. The limited availability of donor organs further restricts market growth, leading to long waiting lists and increased mortality rates among patients in need. Additionally, post-transplant complications such as infections, organ rejection, and side effects of immunosuppressive therapy pose challenges to successful transplant outcomes. Stringent regulatory requirements and ethical concerns regarding organ procurement also impact market expansion.

Market Opportunities:

The market presents significant opportunities driven by technological advancements in organ preservation and transplant techniques. The introduction of machine perfusion technology, which enhances the viability of donor livers and extends preservation time, is expected to improve transplant success rates. The increasing adoption of bioengineering and regenerative medicine, including 3D-printed liver tissues and stem cell therapy, offers promising alternatives to traditional transplantation. Furthermore, growing investments in transplant centers, collaborations between healthcare organizations, and initiatives promoting living donor programs provide new growth avenues. Expanding healthcare access in emerging economies and favorable reimbursement policies also contribute to market development.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Liver Transplantation Market globally?
• How are technological advancements influencing the competitive landscape of the Liver Transplantation Market?
• What are the major challenges faced by liver transplant patients and healthcare providers?
• Who are the key players in the Liver Transplantation Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Liver Transplantation Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Liver Transplantation Market, including healthcare institutions, pharmaceutical companies, and medical device manufacturers, focus on research and development to improve transplant success rates and patient outcomes. Companies invest in developing advanced organ preservation solutions, artificial liver support devices, and improved immunosuppressants to address transplant-related challenges. Collaborations between transplant centers and biotechnology firms are facilitating new treatment modalities, such as xenotransplantation and bioengineered livers. Additionally, initiatives aimed at increasing organ donation rates and improving accessibility to transplantation services are being implemented to drive market growth.

Key Companies Profiled:

• Allosource
• Conatus Pharmaceuticals Inc.
• Digna Biotech S.L.
• Dompe Farmaceutici S.p.A.
• Isogenis, Inc.
• RedHill Biopharma Ltd.
• Thompson Surgical
• Integra Life Sciences
• Baxter International Inc.
• XVIVO
• VirTech Bio

Liver Transplantation Market Research Segmentation

By Product Type:

• Organ Preservation Solutions
• Immunosuppressive Drugs
• Others

By Treatment Type:

• Liver Transplantation Surgery
• Post-Surgery Anti-Rejection Treatment
• Cyclosporine
• Tacrolimus
• Sirolimus Prednisone Azathioprine
• Mycophenolate Mofetil

By End-use:

• Hospitals
• Adult Liver Transplantation Centers
• Ambulatory Surgical Centers

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Liver Transplantation Market Snapshot, 2025 - 2032
• 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Product Type Lifecycle Analysis
• 2.4. Liver Transplantation Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Mn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2019 - 2023
  • 3.2.2. Current Market Size Forecast, 2025 - 2032
• 3.3. Global Liver Transplantation Market Outlook: Product Type
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2019 - 2023
  • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 3.3.3.1. Organ Preservation Solutions
    • 3.3.3.2. Immunosuppressive Drugs
    • 3.3.3.3. Others
• 3.4. Market Attractiveness Analysis: Product Type
• 3.5. Global Liver Transplantation Market Outlook: Treatment Type
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2019 - 2023
  • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 3.5.3.1. Liver Transplantation Surgery
    • 3.5.3.2. Post-Surgery Anti-Rejection Treatment
    • 3.5.3.3. Cyclosporine
    • 3.5.3.4. Tacrolimus
    • 3.5.3.5. Sirolimus Prednisone Azathioprine
    • 3.5.3.6. Mycophenolate Mofetil
• 3.6. Market Attractiveness Analysis: Treatment Type
• 3.7. Global Liver Transplantation Market Outlook: End-use
  • 3.7.1. Introduction / Key Findings
  • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-use, 2019 - 2023
  • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 3.7.3.1. Hospitals
    • 3.7.3.2. Adult liver transplantation centers
    • 3.7.3.3. Ambulatory surgical centers
• 3.8. Market Attractiveness Analysis: End-use

4. Global Liver Transplantation Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
• 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia & Pacific
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 5.3.1. By Country
  • 5.3.2. By Product Type
  • 5.3.3. By Treatment Type
  • 5.3.4. By End-use
• 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 5.5.1. Organ Preservation Solutions
  • 5.5.2. Immunosuppressive Drugs
  • 5.5.3. Others
• 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 5.6.1. Liver Transplantation Surgery
  • 5.6.2. Post-Surgery Anti-Rejection Treatment
  • 5.6.3. Cyclosporine
  • 5.6.4. Tacrolimus
  • 5.6.5. Sirolimus Prednisone Azathioprine
  • 5.6.6. Mycophenolate Mofetil
• 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 5.7.1. Hospitals
  • 5.7.2. Adult liver transplantation centers
  • 5.7.3. Ambulatory surgical centers
• 5.8. Market Attractiveness Analysis

6. Europe Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 6.3.1. By Country
  • 6.3.2. By Product Type
  • 6.3.3. By Treatment Type
  • 6.3.4. By End-use
• 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkey
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 6.5.1. Organ Preservation Solutions
  • 6.5.2. Immunosuppressive Drugs
  • 6.5.3. Others
• 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 6.6.1. Liver Transplantation Surgery
  • 6.6.2. Post-Surgery Anti-Rejection Treatment
  • 6.6.3. Cyclosporine
  • 6.6.4. Tacrolimus
  • 6.6.5. Sirolimus Prednisone Azathioprine
  • 6.6.6. Mycophenolate Mofetil
• 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 6.7.1. Hospitals
  • 6.7.2. Adult liver transplantation centers
  • 6.7.3. Ambulatory surgical centers
• 6.8. Market Attractiveness Analysis

7. East Asia Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 7.3.1. By Country
  • 7.3.2. By Product Type
  • 7.3.3. By Treatment Type
  • 7.3.4. By End-use
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 7.5.1. Organ Preservation Solutions
  • 7.5.2. Immunosuppressive Drugs
  • 7.5.3. Others
• 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 7.6.1. Liver Transplantation Surgery
  • 7.6.2. Post-Surgery Anti-Rejection Treatment
  • 7.6.3. Cyclosporine
  • 7.6.4. Tacrolimus
  • 7.6.5. Sirolimus Prednisone Azathioprine
  • 7.6.6. Mycophenolate Mofetil
• 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 7.7.1. Hospitals
  • 7.7.2. Adult liver transplantation centers
  • 7.7.3. Ambulatory surgical centers
• 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 8.3.1. By Country
  • 8.3.2. By Product Type
  • 8.3.3. By Treatment Type
  • 8.3.4. By End-use
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 8.5.1. Organ Preservation Solutions
  • 8.5.2. Immunosuppressive Drugs
  • 8.5.3. Others
• 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 8.6.1. Liver Transplantation Surgery
  • 8.6.2. Post-Surgery Anti-Rejection Treatment
  • 8.6.3. Cyclosporine
  • 8.6.4. Tacrolimus
  • 8.6.5. Sirolimus Prednisone Azathioprine
  • 8.6.6. Mycophenolate Mofetil
• 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 8.7.1. Hospitals
  • 8.7.2. Adult liver transplantation centers
  • 8.7.3. Ambulatory surgical centers
• 8.8. Market Attractiveness Analysis

9. Latin America Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 9.3.1. By Country
  • 9.3.2. By Product Type
  • 9.3.3. By Treatment Type
  • 9.3.4. By End-use
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 9.5.1. Organ Preservation Solutions
  • 9.5.2. Immunosuppressive Drugs
  • 9.5.3. Others
• 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 9.6.1. Liver Transplantation Surgery
  • 9.6.2. Post-Surgery Anti-Rejection Treatment
  • 9.6.3. Cyclosporine
  • 9.6.4. Tacrolimus
  • 9.6.5. Sirolimus Prednisone Azathioprine
  • 9.6.6. Mycophenolate Mofetil
• 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 9.7.1. Hospitals
  • 9.7.2. Adult liver transplantation centers
  • 9.7.3. Ambulatory surgical centers
• 9.8. Market Attractiveness Analysis

10. Middle East & Africa Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 10.3.1. By Country
  • 10.3.2. By Product Type
  • 10.3.3. By Treatment Type
  • 10.3.4. By End-use
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 10.5.1. Organ Preservation Solutions
  • 10.5.2. Immunosuppressive Drugs
  • 10.5.3. Others
• 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 10.6.1. Liver Transplantation Surgery
  • 10.6.2. Post-Surgery Anti-Rejection Treatment
  • 10.6.3. Cyclosporine
  • 10.6.4. Tacrolimus
  • 10.6.5. Sirolimus Prednisone Azathioprine
  • 10.6.6. Mycophenolate Mofetil
• 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 10.7.1. Hospitals
  • 10.7.2. Adult liver transplantation centers
  • 10.7.3. Ambulatory surgical centers
• 10.8. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2024
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Immunosuppressive Drugs
  • 11.2.3. Apparent Product Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Allosource
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. Conatus Pharmaceuticals Inc.
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Product
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Digna Biotech S.L.
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Product
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. Dompe Farmaceutici S.p.A.
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Product
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. Isogenis, Inc.
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Product
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy
  • 11.3.6. RedHill Biopharma Ltd.
    • 11.3.6.1. Overview
    • 11.3.6.2. Segments and Product
    • 11.3.6.3. Key Financials
    • 11.3.6.4. Market Developments
    • 11.3.6.5. Market Strategy
  • 11.3.7. Thompson Surgical
    • 11.3.7.1. Overview
    • 11.3.7.2. Segments and Product
    • 11.3.7.3. Key Financials
    • 11.3.7.4. Market Developments
    • 11.3.7.5. Market Strategy
  • 11.3.8. Integra Life Sciences
    • 11.3.8.1. Overview
    • 11.3.8.2. Segments and Product
    • 11.3.8.3. Key Financials
    • 11.3.8.4. Market Developments
    • 11.3.8.5. Market Strategy
  • 11.3.9. Baxter International Inc.
    • 11.3.9.1. Overview
    • 11.3.9.2. Segments and Product
    • 11.3.9.3. Key Financials
    • 11.3.9.4. Market Developments
    • 11.3.9.5. Market Strategy
  • 11.3.10. XVIVO
    • 11.3.10.1. Overview
    • 11.3.10.2. Segments and Product
    • 11.3.10.3. Key Financials
    • 11.3.10.4. Market Developments
    • 11.3.10.5. Market Strategy
  • 11.3.11. VirTech Bio
    • 11.3.11.1. Overview
    • 11.3.11.2. Segments and Product
    • 11.3.11.3. Key Financials
    • 11.3.11.4. Market Developments
    • 11.3.11.5. Market Strategy
  • 11.3.12. Vital Therapies
    • 11.3.12.1. Overview
    • 11.3.12.2. Segments and Product
    • 11.3.12.3. Key Financials
    • 11.3.12.4. Market Developments
    • 11.3.12.5. Market Strategy
  • 11.3.13. HepaTx
    • 11.3.13.1. Overview
    • 11.3.13.2. Segments and Product
    • 11.3.13.3. Key Financials
    • 11.3.13.4. Market Developments
    • 11.3.13.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations